Unexpected gamma glutamyltransferase rise increase during levetiracetam monotherapy

Marcella Broli, Federica Provini, Ilaria Naldi, Francesca Bisulli, Claudia Sama, Agostino Baruzzi, Paolo Tinuper, Roberto Riva

Research output: Contribution to journalArticlepeer-review


Levetiracetam is an antiepileptic drug (AED) with a favourable tolerability profile with little or no effect on liver function. We describe an epileptic patient who developed a significant increase in gamma glutamyltransferase (γGT) while on levetiracetam monotherapy.

Original languageEnglish
Pages (from-to)81-82
Number of pages2
JournalEpileptic Disorders
Issue number1
Publication statusPublished - Mar 2010


  • Gamma glutamyltransferase
  • Levetiracetam
  • Liver function

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology


Dive into the research topics of 'Unexpected gamma glutamyltransferase rise increase during levetiracetam monotherapy'. Together they form a unique fingerprint.

Cite this